Spots Global Cancer Trial Database for Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC
Official Title: A Randomized Phase 2 Study Comparing Different Dose Approaches of Induction Treatment (First Cycle) of Regorafenib in Metastatic Colorectal Cancer (mCRC) Patients
Study ID: NCT02835924
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the safety and tolerability of different dose-escalation approaches of regorafenib in mCRC patients.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Spanish Cooperative Group for the Treatment of Digestive Tumors, Madrid, , Spain
Contact Details
Name: Guillem Argiles
Affiliation: Hospital Universitary Vall d'Hebron
Role: STUDY_CHAIR
Name: Josep Mª Tabernero, MD-PhD
Affiliation: Hospital Universitary Vall d'Hebron
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
